201 related articles for article (PubMed ID: 31736445)
21. Graphene oxide as a potential drug carrier - Chemical carrier activation, drug attachment and its enzymatic controlled release.
Trusek A; Kijak E; Granicka L
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111240. PubMed ID: 32806281
[TBL] [Abstract][Full Text] [Related]
22. Graphene Oxide Induced Perturbation to Plasma Membrane and Cytoskeletal Meshwork Sensitize Cancer Cells to Chemotherapeutic Agents.
Zhu J; Xu M; Gao M; Zhang Z; Xu Y; Xia T; Liu S
ACS Nano; 2017 Mar; 11(3):2637-2651. PubMed ID: 28208020
[TBL] [Abstract][Full Text] [Related]
23. Preparation, characterization and anti-cancer activity of graphene oxide-‑silver nanocomposite.
Mariadoss AVA; Saravanakumar K; Sathiyaseelan A; Wang MH
J Photochem Photobiol B; 2020 Sep; 210():111984. PubMed ID: 32771914
[TBL] [Abstract][Full Text] [Related]
24. Protein corona-mediated mitigation of cytotoxicity of graphene oxide.
Hu W; Peng C; Lv M; Li X; Zhang Y; Chen N; Fan C; Huang Q
ACS Nano; 2011 May; 5(5):3693-700. PubMed ID: 21500856
[TBL] [Abstract][Full Text] [Related]
25. Combination of single walled carbon nanotubes/graphene oxide with paclitaxel: a reactive oxygen species mediated synergism for treatment of lung cancer.
Arya N; Arora A; Vasu KS; Sood AK; Katti DS
Nanoscale; 2013 Apr; 5(7):2818-29. PubMed ID: 23443459
[TBL] [Abstract][Full Text] [Related]
26. Reduced graphene oxide-silver nanoparticle nanocomposite: a potential anticancer nanotherapy.
Gurunathan S; Han JW; Park JH; Kim E; Choi YJ; Kwon DN; Kim JH
Int J Nanomedicine; 2015; 10():6257-76. PubMed ID: 26491296
[TBL] [Abstract][Full Text] [Related]
27. Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells.
Wu J; Wang YS; Yang XY; Liu YY; Yang JR; Yang R; Zhang N
Nanotechnology; 2012 Sep; 23(35):355101. PubMed ID: 22875697
[TBL] [Abstract][Full Text] [Related]
28. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
[TBL] [Abstract][Full Text] [Related]
29. In vitro toxicity evaluation of graphene oxide on A549 cells.
Chang Y; Yang ST; Liu JH; Dong E; Wang Y; Cao A; Liu Y; Wang H
Toxicol Lett; 2011 Feb; 200(3):201-10. PubMed ID: 21130147
[TBL] [Abstract][Full Text] [Related]
30. Impact of graphene oxide functionalized with doxorubicin on viability of mouse hepatoma MH-22A cells.
Slekiene N; Snitka V
Toxicol In Vitro; 2020 Jun; 65():104821. PubMed ID: 32151703
[TBL] [Abstract][Full Text] [Related]
31. Biosynthesized of reduced graphene oxide nanosheets and its loading with paclitaxel for their anti cancer effect for treatment of lung cancer.
Lin S; Ruan J; Wang S
J Photochem Photobiol B; 2019 Feb; 191():13-17. PubMed ID: 30557788
[TBL] [Abstract][Full Text] [Related]
32. Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery.
Mauro N; Scialabba C; Agnello S; Cavallaro G; Giammona G
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110201. PubMed ID: 31761243
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous drug delivery and cellular imaging using graphene oxide.
Cheng SJ; Chiu HY; Kumar PV; Hsieh KY; Yang JW; Lin YR; Shen YC; Chen GY
Biomater Sci; 2018 Mar; 6(4):813-819. PubMed ID: 29417098
[TBL] [Abstract][Full Text] [Related]
34. Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress.
Liu S; Zeng TH; Hofmann M; Burcombe E; Wei J; Jiang R; Kong J; Chen Y
ACS Nano; 2011 Sep; 5(9):6971-80. PubMed ID: 21851105
[TBL] [Abstract][Full Text] [Related]
35. Targeted Delivery of Docetaxel by Use of Transferrin/Poly(allylamine hydrochloride)-functionalized Graphene Oxide Nanocarrier.
Nasrollahi F; Varshosaz J; Khodadadi AA; Lim S; Jahanian-Najafabadi A
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13282-93. PubMed ID: 27158834
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive Review on Graphene Oxide for Use in Drug Delivery System.
Daniyal M; Liu B; Wang W
Curr Med Chem; 2020; 27(22):3665-3685. PubMed ID: 30706776
[TBL] [Abstract][Full Text] [Related]
37. Silver nanoparticle-embedded graphene oxide-methotrexate for targeted cancer treatment.
Thapa RK; Kim JH; Jeong JH; Shin BS; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2017 May; 153():95-103. PubMed ID: 28231500
[TBL] [Abstract][Full Text] [Related]
38. Amination of Graphene Oxide Leads to Increased Cytotoxicity in Hepatocellular Carcinoma Cells.
Georgieva M; Vasileva B; Speranza G; Wang D; Stoyanov K; Draganova-Filipova M; Zagorchev P; Sarafian V; Miloshev G; Krasteva N
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244505
[TBL] [Abstract][Full Text] [Related]
39. Recent progress of functionalised graphene oxide in cancer therapy.
Yi L; Zhang Y; Shi X; Du X; Wang X; Yu A; Zhai G
J Drug Target; 2019 Feb; 27(2):125-144. PubMed ID: 29730956
[TBL] [Abstract][Full Text] [Related]
40. Surface Oxidation of Graphene Oxide Determines Membrane Damage, Lipid Peroxidation, and Cytotoxicity in Macrophages in a Pulmonary Toxicity Model.
Li R; Guiney LM; Chang CH; Mansukhani ND; Ji Z; Wang X; Liao YP; Jiang W; Sun B; Hersam MC; Nel AE; Xia T
ACS Nano; 2018 Feb; 12(2):1390-1402. PubMed ID: 29328670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
